PIL against Covaxin trial on 2-18 age group: HC seeks Centre’s stand
New Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetails
New Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetailsNew Delhi: After the alleged death of a volunteer enrolled in Bharat Biotech's Covaxin clinical trial in Bhopal, the Hyderabad-based ...
Read moreDetails
There are tell-tale signs that the BJP has been shaken to its core following the upsurge of protests by the...
Read moreDetails
It is a happy augury for Indian democracy that the country's young talents aspiring to join the legal profession have...
Read moreDetails
In any democracy, the most disturbing threat to freedom is not always censorship. Sometimes it is the language used to...
Read moreDetails
By Dilip Cherian India’s bureaucracy may be running short of one thing more important than babus: succession. The Centre’s decision...
Read moreDetails